SecBot SecBot
144 ·Filed Oct 28, 2026

REPL

Replimune Group, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1d 3h ago SEC0001950047-26-010448
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine insider sale by a director, likely for personal liquidity or tax planning. The small size relative to market cap suggests no material signal. Monitor for any additional insider selling patterns in future filings.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

Executive Summary

Director Veleka Peeples-Dyer filed a Form 144 notice of intent to sell 12,000 shares of Replimune Group common stock, valued at approximately $154,745 based on the filing date. The shares were acquired via stock option exercise, and the sale is planned for execution on the same day as the filing.

Key Facts

  • Insider: Veleka Peeples-Dyer, Director
  • Shares to be sold: 12,000 shares of common stock
  • Approximate value: $154,744.80
  • Acquired via stock option exercise on 10/28/2026
  • Proposed sale date: 10/28/2026
  • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services

Financial Impact

Sale of 12,000 shares valued at ~$155K, representing a small fraction of the $1.2B market cap

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur
  • Director sales are generally less informative than C-suite sales

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
87% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010448
Document: 0001950047-26-010448-index.html0001950047-26-010448
Document: 0001950047-26-010448.txt0001950047-26-010448
22 reports for REPL
Performance horizon
75% Hit rate @ T+60 6 of 8 directional calls Went positive at some point 10 of 13 best @ T+20▲ +188.35%Jul 30, 2026
Filters
Rows
Reports for REPL, sortable and filterable
TypeNow
Oct 28, 2026
1d ago
144
NEUTRAL ★ 2/10
$15.87awaiting T+60awaiting T+60$17.39 (+9.58%)
Oct 28, 2026
1d ago
8-K
NEUTRAL ★ 5/10
No priceawaiting T+60awaiting T+60No price
Oct 28, 2026
1d ago
Press Release
NEUTRAL ★ 5/10
$16.06awaiting T+60awaiting T+60$17.39 (+8.28%)
Oct 22, 2026
7d ago
Press Release
NEUTRAL ★ 1/10
$11.99awaiting T+60awaiting T+60$17.39 (+45.04%)
Aug 19, 2026
10w ago
Insider Cluster
MIXED ★ 6/10
$14.05awaiting T+60awaiting T+60$17.39 (+23.77%)
Aug 14, 2026
10w ago
8-K
BULLISH ★ 7/10
No priceawaiting T+60awaiting T+60No price
Aug 14, 2026
10w ago
Press Release
BULLISH ★ 7/10
$14.97awaiting T+60awaiting T+60$17.39 (+16.17%)
Aug 12, 2026
11w ago
Insider Cluster
MIXED ★ 6/10
$15.19awaiting T+60awaiting T+60$17.39 (+14.48%)
Aug 12, 2026
11w ago
Insider Cluster
BULLISH ★ 7/10
$15.19awaiting T+60awaiting T+60$17.39 (+14.48%)
Aug 10, 2026
11w ago
8-K
BEARISH ★ 6/10
$13.67awaiting T+60awaiting T+60$17.39 (−27.21%)
Showing 10 of 22

US Market Status

Market Closed · Opens Fri (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 28, 2026